| Case report of embryonal rhabdomyosarcoma of the testis with an 8-year survival. | |
| | |
MedLine Citation:
|
PMID: 1159930 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The low incidence of embryonal rhabdomyosarcoma prevents any one person or institution from presenting any meaningful data in the form of effective treatment based on clinical experience. We realize that this is an antidotal case but the stakes are high when treating any malignancy of the young. Therefore, we advocate early and aggressive therapy using all modalities of treatments, and cite this case which initially seemed hopeless but to date has all the hallmarks of a cure. |
| | |
Authors:
|
M J Jungling; D A Culp |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: The Journal of urology Volume: 114 ISSN: 0022-5347 ISO Abbreviation: J. Urol. Publication Date: 1975 Aug |
Date Detail:
|
Created Date: 1975-11-26 Completed Date: 1975-11-26 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0376374 Medline TA: J Urol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 313-5 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Antineoplastic Agents / therapeutic use* Dactinomycin / therapeutic use Humans Lung Neoplasms / pathology Male Methotrexate / therapeutic use Neoplasm Metastasis Prognosis Remission, Spontaneous Rhabdomyosarcoma / drug therapy*, pathology Testicular Neoplasms / drug therapy* Vincristine / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents; 50-76-0/Dactinomycin; 57-22-7/Vincristine; 59-05-2/Methotrexate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Hematuria caused by atheromatous embolism: report of a case diagnosed intravitam.
Next Document: Evaluation of myocardial contractility by the non-invasive method.